XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss)
Common Stock Including Additional Paid in Capital
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2023   18,810,055      
Beginning balance at Dec. 31, 2023 $ 538,387   $ 395,357 $ (86,859) $ 229,889
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (7,497)   (7,497)    
Share-based compensation expense 1,059       1,059
Common stock issued - Stock grants (in shares)   60,483      
Common stock issued - Stock grants 0        
Other comprehensive income (loss) (4,482)     (4,482)  
Common stock repurchased (in shares)   (12,972)      
Common stock repurchased (134)       (134)
Common stock shares outstanding, ending balance (in shares) at Mar. 31, 2024   18,857,566      
Ending balance at Mar. 31, 2024 $ 527,333   387,860 (91,341) 230,814
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2024 18,857,565 18,857,565      
Beginning balance at Dec. 31, 2024 $ 396,997   251,013 (87,201) 233,185
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (4,465)   (4,465)    
Share-based compensation expense 592       592
Common stock issued - Stock grants (in shares)   94,688      
Common stock issued - Stock grants 0        
Other comprehensive income (loss) 7,986     7,986  
Common stock repurchased (in shares)   (31,445)      
Common stock repurchased $ (359)       (359)
Common stock shares outstanding, ending balance (in shares) at Mar. 31, 2025 18,920,808 18,920,808      
Ending balance at Mar. 31, 2025 $ 400,751   $ 246,548 $ (79,215) $ 233,418